|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 384.32 USD | +4.49% |
|
+12.41% | +17.42% |
| 02-06 | Guggenheim Adjusts Price Target on Amgen to $347 From $305, Maintains Neutral Rating | MT |
| 02-06 | Argus Research Adjusts Price Target on Amgen to $400 From $360, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| US$341.93 | -11.03% | 27 | |||||||
| US$1,186.19 | +12.1% | 27 | |||||||
| US$231.25 | -3.64% | 24 | |||||||
| US$245.33 | +9.8% | 27 | |||||||
| CHF 351.3 | -1.43% | 20 | |||||||
| US$121.27 | -0.54% | 26 | |||||||
| GBX 209.44 | +9.11% | 21 | |||||||
| CHF 146.49 | -5.26% | 21 | |||||||
| DKK 385.95 | +30.61% | 22 | |||||||
| US$139.46 | -8.55% | 26 | |||||||
| US$28.71 | +5.48% | 24 | |||||||
| US$59.91 | -3.35% | 23 | |||||||
| US$514.32 | +7.62% | 25 | |||||||
| GBX 18.87 | -14.14% | 20 | |||||||
| €99.14 | +23.37% | 23 | |||||||
| JP¥9,153.33 | +6.34% | 15 | |||||||
| JP¥5,263.07 | -4.6% | 15 | |||||||
| CN¥82.91 | +44.67% | 17 | |||||||
| €42.13 | -8.02% | 20 | |||||||
| Average | 980.05 | +4.66% | 22 | ||||||
| Weighted average by Cap. | 644.77 | +4.45% | 24 |
- Stock Market
- Equities
- AMGN Stock
- Sector Amgen Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















